Screening compound: InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3

Screening compound: InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3
Screening compound: InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L109-0407

Molecular Formula

C18H15ClN4O2 (C18 H15 ClN4 O2)

Compound Name

1-(4-chlorophenyl)-5-(3,4-dimethylphenyl)-1H,3aH,4H,5H,6H,6aH-pyrrolo[3,4-d][1,2,3]triazole-4,6-dione

IUPAC name

1-(4-chlorophenyl)-5-(34-dimethylphenyl)-1H3aH4H5H6H6aH-pyrrolo[34-d][123]triazole-46-dione

SMILES

Cc(cc1)c(C)cc1N(C(C1N(c(cc2)ccc2Cl)N=NC11)=O)C1=O

InChI

InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3

InChI Key

XWODSCGRIDPNRQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27232684

InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
Targets:
  • Proteases
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3?
Check Price and Availability of InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C18H15ClN4O2/c1-10-3-6-14(9-11(10)2)22-17(24)15-16(18(22)25)23(21-20-15)13-7-4-12(19)5-8-13/h3-9,15-16H,1-2H3 available by request